Prevalence of Chronic Kidney Failure and Associated Factors in Patients Treated by Antiretroviral in the National Teaching Hospital of Cotonou

Objectives: To determine the frequency of the chronic kidney failure (CKF) in people living with HIV (PLHIV) on antiretroviral treatment (ART) and to identify associated factors. Methods: This cross-sectional, descriptive and analytical study, conducted in the Outpatient Centre of PLHIV in the National Teaching Hospital of Cotonou from April to July of 2013. Were included, PLHIV aged over 16 years, taking ART for at least three months and having in their file, creatinine at ART initiation. Creatinine was performed at inclusion in the study. Proteinuria was sought on the strip. Chronic kidney failure was defined as creatinine clearance calculated according to Cockcroft-Gault less than 60mL/min for at least 3 months. Factors associated were searched by logistic regression univariate and multivariate analysis. Confidence intervals were calculated at 95% and alpha level was 5%. Results: A total of 480 patients participated in the study (73.3% women; mean age 41.4 ± 9.16 years, in school: 64.6%). The prevalence of chronic kidney failure was 18.7%. The main factors associated in univariate analysis were age (p<0.001), BMI (p<0.001), educational level (p=0.03), the exposure time to ART (p<0.001) and the loss of kidney function at the initiation of ART (p<0.001); in multivariate analysis: age (p<0.001), sex (p<0.001), the body mass index (p<0.001), the loss of kidney function at ART initiation (p=0.034) and didanosine (p=0.007). Discussion and Conclusion: The prevalence of chronic kidney failure in patients receiving ART is high. The creatinine serum in biological monitoring in the ART or better to determine the glomerular filtration rate among PLHIV at least every six (6) months remains a necessity.

[1]  Richard D Moore,et al.  Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care , 2012, AIDS.

[2]  M. Shlipak,et al.  Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  H. Izzedine,et al.  Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional study , 2011, BMC nephrology.

[4]  C. Katlama,et al.  Risk factors of chronic kidney disease in HIV-infected patients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[5]  James E. Novak,et al.  Prevalence of Kidney Disease in HIV-Infected and Uninfected Rwandan Women , 2011, PloS one.

[6]  S. Naicker,et al.  Risk factors for the development of chronic kidney disease with HIV/AIDS. , 2011, Clinical nephrology.

[7]  C. Sabin,et al.  Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure , 2010, AIDS.

[8]  L. Szczech,et al.  Kidney disease in patients with HIV infection and AIDS. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Samir K. Gupta Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system. , 2008, AIDS patient care and STDs.

[10]  F. Arogundade,et al.  Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  P. Volberding,et al.  Racial differences in end-stage renal disease rates in HIV infection versus diabetes. , 2007, Journal of the American Society of Nephrology : JASN.

[12]  H. Furrer,et al.  Tenofovir Use is associated with a Reduction in Calculated Glomerular Filtration Rates in the Swiss HIV Cohort Study , 2007, Antiviral therapy.

[13]  I. Barash,et al.  Chronic kidney disease in HIV infection: an urban epidemic , 2007, AIDS.

[14]  S. Naicker,et al.  Chronic kidney disease in human immunodeficiency virus infection. , 2007, Panminerva medica.

[15]  A. Mocroft,et al.  Chronic renal failure among HIV-1-infected patients , 2007, AIDS.

[16]  Michelle Le Braz,et al.  No change in calculated creatinine clearance after tenofovir initiation among Thai patients. , 2007, The Journal of antimicrobial chemotherapy.

[17]  V. Falcó,et al.  Renal safety of tenofovir disoproxil fumarate in HIV-1 treatment-experienced patients with adverse events related to prior NRTI use: data from a prospective, observational, multicenter study. , 2006, Journal of acquired immune deficiency syndromes.

[18]  K. Tashima,et al.  Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  G. Mcgwin,et al.  Factors associated with chronic renal failure in HIV-infected ambulatory patients , 2004, AIDS.

[20]  R. Haubrich,et al.  Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy. , 2008, The Journal of infectious diseases.

[21]  Mardge H. Cohen,et al.  Predictors of proteinuria and renal failure among women with HIV infection. , 2002, Kidney international.

[22]  V. D’Agati,et al.  HIV infection and the kidney. , 1997, Journal of the American Society of Nephrology : JASN.